2 July, 2025
Our new solution for our Medical Devices clients: V&V Strategy Assessment
At GXP CONSULTING, we’re excited to introduce a new service tailored to one of the critical stages of medical device development: Verification & Validation (V&V).
19 June, 2025
Quick Impact Assessment – Project Plan Review for MedTech industries
We are pleased to announce the launch of a new high-value support format designed specifically for MedTech companies: the Quick Impact Assessment – Project Plan Review.
19 June, 2025
Participation in the A3P Switzerland Forum on Microbiology - June 17, 2025
On June 17, 2025, we were pleased to participate in the A3P Switzerland Forum on Microbiology, a key industry event focused on the latest advances in microbiological methods and technologies.
3 June, 2025
Reimagining Compliance for the Pharmaceutical and Biotech Sectors
In the rapidly evolving landscape of the pharmaceutical and biotechnology industries, regulatory compliance is no longer just a box to check, it has become a key driver of operational resilience and competitive advantage.
At GXP CONSULTING, we recognize that many organizations still face challenges in managing compliance processes that are often complex, manual, and resource-intensive. That’s why leverage a digital solution designed to transform compliance into a strategic asset.
